Literature DB >> 1430200

Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

N Dalla Venezia1, F Gilsanz, N Alloisio, M T Ducluzeau, E J Benz, J Delaunay.   

Abstract

We studied a 43 yr-old Spanish patient with homozygous 4.1(-) hereditary elliptocytosis. Any form of protein 4.1 was missing in the red cells. Spectrin and actin were slightly, yet significantly, diminished. Alterations appeared at the level of proteins 4.5 and 4.9. Glycophorin C was sharply reduced. The abnormal allele was associated with the -++-- haplotype (Pvu II, Bgl II, Bgl II, Pvu II, Pvu II). mRNA 4.1(-) had an apparently normal size but was diminished by about two-thirds. Because the abnormal phenotype pertained to the red cell, we sequenced the 4.1 cDNA regions that appear critical to this cell type. The ultimate change turned out to be a point mutation of the downstream translation initiation codon (AUG-->AGG). No disorders in other cell types could be related with certainty to the present 4.1(-) HE allele.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430200      PMCID: PMC443228          DOI: 10.1172/JCI116044

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Elliptocytogenic alpha I/36 spectrin Sfax lacks nine amino acids in helix 3 of repeat 4. Evidence for the activation of a cryptic 5'-splice site in exon 8 of spectrin alpha-gene.

Authors:  F Baklouti; J Maréchal; R Wilmotte; N Alloisio; L Morlé; M T Ducluzeau; L Denoroy; A Mrad; M H Ben Aribia; R Kastally
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

Review 2.  The red cell skeleton and its genetic disorders.

Authors:  J Delaunay; N Alloisio; L Morlé; B Pothier
Journal:  Mol Aspects Med       Date:  1990

3.  O-N-acetyl-D-glucosamine moiety on discrete peptide of multiple protein 4.1 isoforms regulated by alternative pathways.

Authors:  M Inaba; Y Maede
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

4.  Partial deficiency of protein 4.1 in hereditary elliptocytosis.

Authors:  S Lambert; S Zail
Journal:  Am J Hematol       Date:  1987-11       Impact factor: 10.047

5.  Gerbich reactivity in 4.1 (-) hereditary elliptocytosis and protein 4.1 level in blood group Gerbich deficiency.

Authors:  D Sondag; N Alloisio; D Blanchard; M T Ducluzeau; P Colonna; D Bachir; C Bloy; J P Cartron; J Delaunay
Journal:  Br J Haematol       Date:  1987-01       Impact factor: 6.998

6.  Distinct variants of erythrocyte protein 4.1 inherited in linkage with elliptocytosis and Rh type in three white families.

Authors:  M McGuire; B L Smith; P Agre
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

7.  Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton.

Authors:  J Conboy; Y W Kan; S B Shohet; N Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide.

Authors:  R A Anderson; V T Marchesi
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

9.  Phorbol ester- and Ca2+-dependent phosphorylation of human red cell membrane skeletal proteins.

Authors:  C M Cohen; S F Foley
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

10.  Visualization of the hexagonal lattice in the erythrocyte membrane skeleton.

Authors:  S C Liu; L H Derick; J Palek
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more
  8 in total

Review 1.  Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

Authors:  E J Benz; S C Huang
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

2.  Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.

Authors:  Omar Niss; Satheesh Chonat; Neha Dagaonkar; Marya O Almansoori; Karol Kerr; Zora R Rogers; Patrick T McGann; Maa-Ohui Quarmyne; Mary Risinger; Kejian Zhang; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2016-07-17       Impact factor: 3.039

3.  Protein 4.1 deficiency associated with an altered binding to the spectrin-actin complex of the red cell membrane skeleton.

Authors:  F Lorenzo; N Dalla Venezia; L Morlé; F Baklouti; N Alloisio; M T Ducluzeau; L Roda; P Lefrançois; J Delaunay
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.

Authors:  Z T Shi; V Afzal; B Coller; D Patel; J A Chasis; M Parra; G Lee; C Paszty; M Stevens; L Walensky; L L Peters; N Mohandas; E Rubin; J G Conboy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins.

Authors:  Kris P Jeremy; Zoe E Plummer; David J Head; Tracey E Madgett; Kelly L Sanders; Amanda Wallington; Jill R Storry; Florinda Gilsanz; Jean Delaunay; Neil D Avent
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

6.  Rhmod syndrome: a family study of the translation-initiator mutation in the Rh50 glycoprotein gene.

Authors:  C Huang; G J Cheng; M E Reid; Y Chen
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

7.  ICln: a new regulator of non-erythroid 4.1R localisation and function.

Authors:  Claudia Bazzini; Lorena Benedetti; Davide Civello; Chiara Zanoni; Valeria Rossetti; Davide Marchesi; Maria Lisa Garavaglia; Markus Paulmichl; Maura Francolini; Giuliano Meyer; Simona Rodighiero
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

8.  Exome sequencing results in successful diagnosis and treatment of a severe congenital anemia.

Authors:  Jessica N Lacy; Jacob C Ulirsch; Rachael F Grace; Meghan C Towne; John Hale; Narla Mohandas; Samuel E Lux; Pankaj B Agrawal; Vijay G Sankaran
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.